Patients often see long-term improvements in cardiovascular health, reduced risk of diabetes-related complications, and an enhanced quality of life
Not intended for human consumption, therapeutic use, diagnosis or treatment of any condition
A study highlighted results of participants losing about 16 percent of their body weight, which translates to roughly 35 pounds
Additionally, UnionDerm was one of the clinical trial sites that led to the FDA approval of Restylane Eyelight for improving the appearance of depressed, sunken, or hollow areas under the eyes
With our tirzepatide and semaglutide weight loss, Scottsdale, AZ, patients often report breakthroughs after years of stalled progress